Your browser doesn't support javascript.
loading
A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer.
Spetsieris, Nicholas; Boukovala, Myrto; Weldon, Justin A; Tsikkinis, Alexandros; Hoang, Anh; Aparicio, Ana; Tu, Shi-Ming; Araujo, John C; Zurita, Amado J; Corn, Paul G; Pagliaro, Lance; Kim, Jeri; Wang, Jennifer; Subudhi, Sumit K; Tannir, Nizar M; Logothetis, Christopher J; Troncoso, Patricia; Wang, Xuemei; Wen, Sijin; Efstathiou, Eleni.
Afiliação
  • Spetsieris N; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Boukovala M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Weldon JA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tsikkinis A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hoang A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Aparicio A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tu SM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Araujo JC; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Zurita AJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Corn PG; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pagliaro L; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kim J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Subudhi SK; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tannir NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Troncoso P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wen S; Department of Biostatistics, West Virginia University School of Public Health, Morgantown, WV.
  • Efstathiou E; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: eefstathiou@mdanderson.org.
Clin Genitourin Cancer ; 19(1): 22-31.e5, 2021 02.
Article em En | MEDLINE | ID: mdl-32675015
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article